No. |
Drug (Description in trials) |
DrugBank |
KEGG DRUG * |
KEGG GENES * [Number of genes] |
KEGG PATHWAY [Number of pathways] |
Disease ID * [Number of diseases] |
1 |
Cozaar 50 mg comprimidos recubierto con pelicula |
Losartan |
D00357, D08146 |
[1] AGTR1 |
[14] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
[1] 179 |
2 |
Fluoxetin |
Fluoxetine |
D00326, D00823 |
[1] SLC6A4 |
[2] Serotonergic synapse, Synaptic vesicle cycle |
[3] 13, 179, 206 |
3 |
Lonoten |
- |
- |
- |
- |
[1] 179 |
4 |
Losartan |
Losartan |
D00357, D08146 |
[1] AGTR1 |
[14] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
5 |
Losartan potasico |
Losartan |
D00357, D08146 |
[1] AGTR1 |
[14] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
[1] 179 |
6 |
Losartan potassium |
Potassium |
D08403 |
- |
- |
[4] 98, 167, 179, 215 |
7 |
Methylphenidate |
Methylphenidate |
D01296, D04999 |
[2] SLC6A2, SLC6A3 |
[6] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle |
[7] 6, 13, 34, 84, 113, 179, 206 |
8 |
Methylphenidate, fluoxetin, risperidone |
Methylphenidate |
D01296, D04999 |
[2] SLC6A2, SLC6A3 |
[6] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Synaptic vesicle cycle |
[2] 179, 206 |
9 |
Minoxidil |
Minoxidil |
D00418 |
[2] ABCC8, KCNJ11 |
[4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
[1] 179 |
10 |
Potassium |
Potassium |
D08403 |
- |
- |
[9] 46, 66, 67, 98, 115, 167, 179, 215, 235 |
11 |
Risperidone |
Risperidone |
D00426 |
[2] DRD2, HTR2A |
[11] Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway |
[5] 8, 156, 179, 187, 206 |
12 |
Vitamin d |
Vitamin d |
- |
- |
- |
[18] 13, 19, 41, 46, 49, 50, 68, 93, 95, 96, 98, 179, 222, 228, 235, 274, 298, 299 |